Addus HomeCare (NASDAQ:ADUS) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Key Points

• Addus HomeCare reported $1.31 earnings per share for the quarter, missing analyst expectations by $0.14.
• The stock's current market capitalization stands at $1.97 billion, with shares trading around $106.96.
• Research analysts have a consensus target price of $142.57 for Addus HomeCare, with several recently reaffirming a "buy" rating on the stock.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) issued its earnings results on Monday. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04, Briefing.com reports. Addus HomeCare had a return on equity of 9.51% and a net margin of 6.51%. The company had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. During the same period last year, the business posted $1.35 EPS. The firm's revenue for the quarter was up 21.8% compared to the same quarter last year.

Addus HomeCare Stock Performance

ADUS traded down $0.96 during midday trading on Wednesday, reaching $115.61. The company had a trading volume of 114,539 shares, compared to its average volume of 190,963. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. The business has a 50-day moving average of $111.82 and a two-hundred day moving average of $108.33. The company has a market cap of $2.13 billion, a P/E ratio of 25.53, a P/E/G ratio of 1.51 and a beta of 0.80. Addus HomeCare has a 1 year low of $88.96 and a 1 year high of $136.72.

Analysts Set New Price Targets

ADUS has been the subject of several research reports. Macquarie reiterated an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, JMP Securities reissued a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Seven analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Buy" and an average target price of $142.57.

Insiders Place Their Bets

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president directly owned 7,796 shares in the company, valued at $896,540. The trade was a 20.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 4.60% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of ADUS. Royal Bank of Canada increased its position in Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company's stock valued at $682,000 after acquiring an additional 1,347 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Addus HomeCare by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company's stock valued at $1,026,000 after purchasing an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company's stock worth $5,111,000 after purchasing an additional 2,952 shares in the last quarter. Jane Street Group LLC boosted its stake in Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company's stock valued at $1,092,000 after acquiring an additional 8,780 shares during the period. Finally, Intech Investment Management LLC raised its holdings in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company's stock valued at $1,420,000 after buying an additional 4,439 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.